Business Wire

SEIKO-INSTRUMENTS-INC.

Del
Seiko Instruments Introduces New 1-cell Lithium-ion Battery Protection ICs Incorporated in Ultra-Small 1.2 x 1.2 mm Package

Seiko Instruments Inc. (SII) announced the release of the S-8240 Series, 1-cell lithium-ion battery protection IC available in an ultra-small package (1.2 x 1.2 x 0.4 mm). The S-8240 features an industry leading ±5mV charge and discharge overcurrent detection voltage accuracy and ultra-low 1.5µA current consumption. The S-8240 has been optimized for use in smart phones, wearable devices, and other battery-operated portable device designs.

Lithium-ion battery protection ICs protect lithium-ion batteries from failure including over-charging, over-discharging, over-current, and short-circuiting.

Leveraging SII’s HSNT-6 (1212) ultra-small package, the S-8240 requires only half the footprint of SII’s conventional SNT-6A packaged ICs and is ultra-light weight at 1.6 mg. These key features help to save precious space and meet the designer’s needs for creating small, thin, and lightweight battery packs. The high-precision ±5mV charge and discharge overcurrent detection voltage accuracy helps allow for higher reliability and safety of lithium-ion battery packs when compared to those with typical industry accuracy of ±10mV to ±15mV. The ultra-low 1.5µA current consumption during operation helps to prolong battery runtime when compared to typical battery protection IC current consumption of nearly twice this amount.

At the same time, SII releases the new 1-cell secondary protection IC S-8206A Series to enhance the safety of 1-cell lithium battery protection ICs, as well as the battery monitoring IC S-8259A Series that allows simplified design of multi-cell protection circuits by monitoring each cell.

Developed with high-accuracy and low current consumption, SII’s lithium-ion battery protection ICs hold a dominant global market share. SII continues to add new innovative products and expand our broad product portfolio of battery protection ICs for 1-cell to multi-cell packs to further meet the diverse needs of customers.

Detailed information:
1-cell Lithium-ion Battery Protection IC S-8240A Series
http://datasheet.sii-ic.com/en/battery_protection/S8240A_E.pdf
1-cell second protection IC S-8206A Series
http://datasheet.sii-ic.com/en/battery_protection/S8206A_E.pdf
Battery monitoring IC S-8259A Series
http://datasheet.sii-ic.com/en/battery_protection/S8259A_E.pdf

Please visit:
English: http://www.sii-ic.com/en/

About Seiko Instruments Inc. (SII)
Major subsidiary of Seiko Holdings Corporation (TOKYO:8050). Develops, manufactures and sells watches, semiconductors, crystal oscillators, micro batteries, inkjet printheads, hard disk components, thermal printers, factory automation systems, color printers, etc.
http://www.sii.co.jp/en/

Contact:

Seiko Instruments Inc.
Yasuko Arai, +81-43-211-1111 (Japanese inquiry only)
Corporate Communications Dept.
pr@sii.co.jp
Online Inquiry: https://krs.bz/sii/m/sii_inquiry_en

Link:

Multimedia Gallery

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release

Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,

LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release

~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut

The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release

The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the

Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release

Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye